Efficacy of Acupuncture on Chronic Pelvic Pain in Women With Endometriosis or Adenomyosis
NCT ID: NCT01259180
Last Updated: 2010-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2010-12-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupuncture group
twice a week, 6 weeks real acupuncture treatment, 12 sessions
acupuncture treatment
twice a week, 6 weeks, 12sessions penetrating skin with stailess steel acupuncture device(diameter: 0.25-0.3mm,legth: 30-70mm) points: BL 23,BL31,BL32, BL40, BL53, GB30, SP 6 bilaterally plus Ashi. with
Sham acupuncture group
twice a week, 6 weeks real acupuncture treatment, 12 sessions
Sham acupunture
twice a week, 6 weeks, 12 sessions not penetrating skin with dull acupuncture device(Park Sham device :Acuprime Co. Ltd, UK) point: 1\~2inches away from real acupuncture point
Control group
observation.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture treatment
twice a week, 6 weeks, 12sessions penetrating skin with stailess steel acupuncture device(diameter: 0.25-0.3mm,legth: 30-70mm) points: BL 23,BL31,BL32, BL40, BL53, GB30, SP 6 bilaterally plus Ashi. with
Sham acupunture
twice a week, 6 weeks, 12 sessions not penetrating skin with dull acupuncture device(Park Sham device :Acuprime Co. Ltd, UK) point: 1\~2inches away from real acupuncture point
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who have been on GnRH agonist treatment for 6 months after being diagnosed Endometriosis or Adenomyosis
* Patients who agreed a written consent by their own will
* Patients' compliance and geographical adjacency appropriate for proper follow up survey
* continuous pelvic pain over VAS 5 during past 1 week on screening visit(after 6 weeks of surgery) (0='no pain', '10=most severe')
Exclusion Criteria
* Patients found to have malignant tumor of uterus and adenexa, PID or pregnancy during surgery
* Allergies to metal or contraindications for acupuncture treatment (ex: coagulopathy, epilepsy)
* Unable to participate in clinical trial by doctor's judgment
* irritable bowel syndrome
16 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
East West Neo Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
East-West Neo Medical center clinical medicine institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jin-Moo Lee, OMD
Role: STUDY_DIRECTOR
East West Neo Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East-West Neo Medical Center
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ji Yung Lee, OMD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUIMS-pp-10
Identifier Type: -
Identifier Source: org_study_id